BDC Capital's $150M Life Sciences Fund: Canada's Medtech Layer Gets Capital
BDC Capital's life sciences venture fund bolsters Canadian therapeutics and medtech — an underrated pipeline for U.S. and EU follow-on rounds.
2026-vc-news - VC Tracker Resources
Discover comprehensive resources and guides related to 2026-vc-news. Our comprehensive guides cover VC analysis preparation, investment resources, and practical advice for investors and analysts.
Whether you're an investor preparing for market analysis, a portfolio manager helping with investment tracking, or an analyst looking for resources, you'll find valuable insights in the articles below.
Related Articles (119 articles)
Jeito Capital II's €1B European Biopharma Fund: LPs Back EU Healthcare at Scale
Jeito Capital's €1B Fund II cements the case that Europe can fund late-stage biopharma domestically, without exporting all growth-stage capital to the U.S.
Blackstone's $10B Capital Opportunities V: Private Credit Reshapes the VC Exit Path
Blackstone's opportunistic private credit fund is not VC, but its scale directly changes how venture-backed companies refinance, recapitalize, and exit.
KKR's $23B North America PE Fund: Scale Capital Reshapes the Growth-Stage VC Market
Mega buyout funds like KKR's 2026 vehicle aren't traditional VC, but they materially influence late-stage startup exits and crossover rounds.
Alcatraz's $50M Series B: Physical Security Is Being Rebuilt for the AI Infrastructure Era
Alcatraz's April 2026 round reflects growing demand for privacy-aware biometric access systems in critical facilities.
April 2026 NYC + U.S. VC Funding Roundup: What the Latest Deals Signal for Q2
From NYC seed activity to U.S. AI infrastructure rounds, April 2026 deal flow shows where capital is concentrating and what founders should do next.